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Abstract
Xenon is frequently used as a general anesthetic in humans, but the mechanism remains an
issue of debate. While for some membrane proteins, a direct interaction of xenon with the
protein has been shown to be the inhibitory mechanism, other membrane protein functions
could be affected by changes of membrane properties due to partitioning of the gas into the
lipid bilayer. Here, the effect of xenon on a mechanosensitive ion channel and a copper ion-
translocating ATPase was compared under different conditions. Xenon inhibited spontane-
ous gating of the Escherichia coli mechano-sensitive mutant channel MscL-G22E, as
shown by patch-clamp recording techniques. Under high hydrostatic pressure, MscL-inhibi-
tion was reversed. Similarly, the activity of the Enterococcus hirae CopB copper ATPase,
reconstituted into proteoliposomes, was inhibited by xenon. However, the CopB ATPase
activity was also inhibited by xenon when CopB was in a solubilized state. These findings
suggest that xenon acts by directly interacting with these proteins, rather than via indirect
effects by altering membrane properties. Also, inhibition of copper transport may be a novel
effect of xenon that contributes to anesthesia.
Introduction
There has been substantial interest in using noble gases as ’ideal’ general anesthetics for more
than half a century [1,2]. Noble gases are also useful as a tool in biophysical studies of proper-
ties of biological membranes and their protein constituents. Being chemically inert, noble
gases have preferential affinity for the hydrophobic environment, which provides an opportu-
nity to directly manipulate the functioning of phospholipid membranes [3–5]. The effective-
ness of volatile anesthetics follows the Meyer-Overton rule [6,7], which states that a greater
solubility in olive oil is correlated to a greater anesthetic potency [8]. This describes, but does
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not explain the anesthetic effects. It has remained a matter of debate whether volatile anesthet-
ics solely work by nonspecific effects on the membrane, or also via a specific interaction with
membrane receptors, pumps, or channels.
As xenon is highly soluble in the lipid bilayer, its presence will affect the properties of the
bilayer. In particular, when dissolved in phospholipid bilayers, xenon influences parameters
such as membrane thickness [5], lateral pressure profile [9], melting point and phase transition
temperature [4]. By altering membrane properties, xenon may affect the function of integral
membrane proteins indirectly. On the other hand, it was shown that xenon also binds to
hydrophobic sites within proteins. This was demonstrated for both, soluble proteins and inte-
gral membrane proteins. X-ray diffraction studies of a number of enzymes have revealed that
xenon binds to hydrophobic cavities in proteins through weak but specific dipole-induced
dipole interactions [10]. In the membrane-embedded cytochrome ba3 oxidase of Thermus
thermophilus, xenon atoms were shown to line the hydrophobic channel that provides access
of O2 to the a3-CuB center [11].
The GABAergic system has been considered as a prime target for mediating the anesthetic
effects of xenon [12–14]. More recently, xenon was shown to competitively inhibit the N-
methyl-D-aspartate receptor by binding to the glycine binding site [15][16]. Xenon also acts
on other channels like TREK-1 or adenosine triphosphate-sensitive potassium (KATP) chan-
nels and several of these inhibitory effects contribute to the neuroprotection against traumatic
brain injury by xenon [17–19]. Detailed mapping of the xenon binding sites by X-ray crystal-
lography was conducted on the ligand-gated ion channel GLIC of Gloebacter violaceus [20].
GLIC is a member of the pLGIC family, which also includes serotonin, n-acetylcholine, gly-
cine, and GABA receptors. Xenon binding to three distinct regions in the trans-membrane
domain of GLIC was observed: to an intra-subunit cavity, at the interface between adjacent
subunits, and in the pore, which was effectively sealed by the bound xenon. Clearly, intra-pro-
tein binding of xenon is a pharmacologically relevant mechanism, although this does not rule
out the possibility that xenon directly affects membrane properties, which can in turn affect
the function of integral membrane proteins within.
To compare the effects of xenon on a protein under different membrane conditions, we
measured xenon-inhibition of the mechano-sensitive channel of large conductance (MscL) of
Escherichia coli at ambient and high pressure and the copper transporting ATPase CopB of
Enterococcus hirae in solution and in a membrane-bound state. MscL is a robust mechano-sen-
sitive channel for multiple ions (non-selective) and its gating activity can be modulated by
physical [21–23] or chemical [24–28] means. MscL of E. coli is homologous to MscL of Myco-
bacterium tuberculosis, for which an X-ray structure is available [29]. The crystal structure
shows that the channel is a homo-pentamer. Each monomer contains two transmembrane
helices and has the N- and C-terminal domains located on the cytoplasmic side of the mem-
brane. The first of the two transmembrane domains that exist per subunit contain a cluster of
hydrophobic residues which form a ‘hydrophobic lock’ within the pentameric channel pore.
Membrane thickness and hydrophobic mismatch between the MscL protein and the mem-
brane have a direct impact on the functional state of wild-type MscL [21,23,25,26]. In this
study, we used a G22E mutant of E. coli MscL (MscL-G22E) to evaluate the effects of xenon on
the channels gating activity. The G22E mutation induces the channel to spontaneously open
with a gating function without a tension being deliberately applied to the membrane. It was
found that xenon completely inhibits the spontaneous activity of MscL-G22E. This effect
could be reversed by applying increased hydrostatic pressure to membrane patches containing
these channels, suggesting direct effects of xenon on the protein.
To obtain further evidence for direct effects of xenon on a membrane protein, we used the
CopB copper ATPase of E. hirae [30]. The copper pumping activity by CopB is directly linked
Xenon-inhibition of MscL and CopB
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to ATP hydrolysis: if no copper ions are available for transport, no ATP hydrolysis takes place
[31]. This allows the recording of CopB activity not only in a membrane environment, but also
in a solubilized state in the absence of phospholipids by monitoring ATP hydrolysis. Xe inhib-
ited CopB in both, the membrane-bound and the solubilized state. These observations suggest
that xenon primarily exerts its inhibitory effect directly on the membrane proteins studies
here, rather than via changes of membrane properties.
Materials and methods
Cell-free expression construct and MscL-G22E
Wild-type MscL was PCR-amplified from the MscL pGEX1.1 expression vector [32], employ-
ing primers 5’-gacctgcagctggttccgcgtgga and 5’-attaagctttcaggcgcttgtta, followed by subcloning
into pQE-31 (Qiagen, Germantown, MD), cut with PstI and HindIII. In the resulting clone,
MscL 2.1, MscL is endowed with a thrombin-cleavable N-terminal histidine tag, resulting in
the following amino acid sequence before MscL’s Met1: MRGSHHHHHHTDPHASSVPRVDLQL
VPRGSLEHRENN. The N-terminus after thrombin cleavage is underlined. For cell-free expres-
sion using E. coli extracts, the coding sequence was subcloned by PCR with primers 5’-AAA
TTTCATATGAGAGGATCTCACCAT and 5’-TAGGTAAAGCTTTCAGGCGCTTGT into the
NdeI and HindIII sites of pET-17b (Novagen), resulting in clone MscL 3.1. The MscL-G22E
mutation was obtained by site-directed mutagenesis of clone MscL 2.1 with the QuikChange II
kit (Stratagene, La Jolla, CA), using primers 5'-gtggatttggcggtggaggtcattatcggt
gcgg and 5'-ccgcaccgataatgacctccaccgccaaatccac.
MscL-G22E was produced using a cell-free expression system essentially as described previ-
ously [33]. Briefly, the inner reaction was scaled to 2.52 mL with 30 mL outer buffer, and incu-
bated for 13 h with longitudinal shaking at 200 min-1 and a -inch stroke at 37 ˚C. The inner
reactions were centrifuged for 20 min at 12,000 x g at 4 ˚C. An 8 μL aliquot of each supernatant
was run on a 12% SDS-polyacrylamide gel for analysis. MscL-G22E was solubilized with 1% n-
dodecyl-β-D-maltoside (Affymetrix, Santa Clara, CA) and combined with 450 μL of PBS-
washed Talon metal affinity resin (Clontech, Mountain View, CA) to allow binding to the
6His-MscL-G22E for 2 h. The resin was then pelleted and washed with 1 mM n-dodecyl-β-D-
maltoside in PBS pH 7.5, and re-suspended to a final volume of 100 μL in the same buffer.
MscL-G22E was released from the affinity resin by cleavage with 0.58 U of thrombin (Biopur,
Bubendorf, Switzerland) at 4 ˚C for three days. MscL released from the column was analyzed
by SDS gel electrophoresis (Figure A in S1 File).
Liposome reconstitution of MscL-G22E
Purified MscL-G22E was reconstituted into soybean phospholipid liposomes using a dehydra-
tion/rehydration (D/R) technique, modified from Ha¨se et al. [32] and Delcour et al. [34]: 20
mg of dry soybean phospholipids were placed in a glass centrifuge tube and dissolved in 1–2
mL of chloroform. The chloroform was evaporated with a stream of nitrogen with constant
rotating of the tube to form a uniform lipid layer without lumps, followed by 20 min of drying
with a stronger N2 stream. The dried soybean phospholipids were resuspended in 2 mL of D/R
buffer (200 mM KCl, 5mM K-HEPES, pH 7.2) using a small brush, followed by sonication for
10 min in a bath sonicator to obtain a transparent, opalescent suspension. MscL-G22E was
mixed with 200 μL of lipid suspension to achieve a protein/lipid mass ratio of 1:1000. The mix-
ture was diluted with D/R buffer to 3 mL and mixed on a platform rocker for 1 h, then 20–30
mg of Biobeads (BioRad, Hercules, CA) were added for a further 3 h. The beads were allowed
to settle, and the supernatant was centrifuged at 440,000 x g for 30 min. The pellet was resus-
pended in 40 μL D/R buffer and 20 μL aliquots were put as spots on microscope cover glasses
Xenon-inhibition of MscL and CopB
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and dehydrated overnight in a desiccator. The spots were then rehydrated by placing 15–20 μL
of D/R buffer on each spot and left for 24 h at 4 ˚C. A small amount (1–2 μL) of proteolipo-
somes was placed in the recording chamber containing the recording solution. Thin-walled
bubbles started to appear on the sides of lumps of lipid after 10–20 min and were used for
patch-clamping.
Patch clamp and “flying-patch” electrophysiology of MscL-G22E
Spontaneous activity of MscL-G22E was recorded using the patch clamp technique in voltage
clamp mode [35]. For measurements at increased hydrostatic pressure, the “flying-patch”
methodology previously described was used; it is chiefly a mechanical device that allows easy
transfer a membrane patch to high-pressure conditions [36,37]. If MscL-G22E was active for
at least 5 min, recording and data analysis were conducted as previously described [36,37]. All
recordings were repeated 3 to 7 times.
Measurements with xenon
To saturate buffer with xenon, a 500-ml bottle containing buffer was attached to a cyclic satu-
rator (Figure B in S1 File) and xenon was pumped through the solution at 4 ˚C overnight.
Xenon-saturated solutions were stored in 5 mL aliquots in sealed syringes at -80 ˚C. The effec-
tiveness of Xe-saturation of solutions was measured by mass spectrometry with a DSQ II Dual
Stage Quadrupole GC/MS spectrometer, using the 132Xe isotope and calibration with gas sam-
ples containing 5%, 15% and 100% of xenon in air at atmospheric pressure. Based on the cali-
bration curves (Figure C in S1 File), the xenon-saturated buffers contained ~6% (v/v) Xe. To
determine the effects of xenon on protein activities, xenon-saturated buffer was added to patch
clamp recordings or was used as assay buffer to measure ATPase activities. Since xenon dif-
fuses only very slowly out of solution, the assays could be performed without any further
precautions.
CopB ATPase purification
The E. hirae mutant Yl that lacks the CopY repressor and thus overexpresses the cop operon
about 50-fold was used for CopB purification [38]. Y1 cells were grown in semi anaerobic con-
ditions in two liters of N-media (60 mM Na2HPO4, 1% peptone, 0.5% yeast extract, 1% glu-
cose, pH 7.8–8.0) at 37 ˚C to an OD at 600 nm of 1 to 1.5 and centrifuged at room temperature
for 12 min at 8000 x g. The cells were washed in 1/10 volume of 2 mM MgSO4 by centrifuging
at room temperature for 12 min at 8000 x g. The wet weight of the cells was determined and
cells were resuspended in 6 mL/g wet cells of 250 mM K2SO4, 2 mM MgSO4, 50 mM
K-HEPES, pH 7.2. Lysozyme (4 mg/g wet cells) was added and the suspension incubated in a
shaking water bath at 37 ˚C for 45 min. Then, 200 μg/g of wet cells of DNase 1 was added and
incubation continued for 15 min. The cells were centrifuged for 12 min at 23,000 x g and 4 ˚C
and resuspended in 2 ml/g wet cells of 20 mM Tris-SO4 pH 7.5, 5 mM MgSO4, 25 mM
Na2SO4, 25 mM K2SO4, 1 mM β-mercaptoethanol, 1 μM CuSO4, 20% (v/v) glycerol) and 1/
100 volume of protease inhibitor cocktail (Table A in S1 File) and the pellet re-suspended
using a Potter-Elvehjem homogenizer at 1000 rpm. Cells were then lysed by passing the sus-
pension twice through a French press at 20 MPa. Cells and membranes were collected by cen-
trifugation for 60 min at 90000 x g at 4 ˚C. The membrane pellet was resuspended in 0.66 mL
of buffer G per g wet of cells and frozen at -20 ˚C. The membrane protein concentration was
determined with the Bradford assay [39], using bovine serum albumin as the standard. Frozen
membrane suspensions were stable for 3 months.
Xenon-inhibition of MscL and CopB
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For CopB extraction, frozen membrane suspensions were thawed, 1/200 volume of protease
inhibitor cocktail (Table A in S1 File) and 1 g of dodecyl-β-D-maltoside were added and the
suspension was stirred on ice for 1 h. Extracted membranes were removed by centrifugation
for 45 min at 90,000 x g and 4 ˚C. All further steps were conducted at 4 ˚C. The supernatant
was supplemented with 10 mM imidazole-SO4 pH 7.5 and loaded onto a Ni-NTA-column,
pre-equilibrated with JD-buffer [20 mM Tris-SO4 pH 7.5, 5 mM MgSO4, 1 mM β-mercap-
toethanol, 1 μM CuSO4, 20% glycerol, 0.05% dodecyl-β-D-maltoside (DM)]. The column was
washed with JD-buffer containing 10 mM imidazole-SO4 pH 7.5, followed by JD-buffer con-
taining 50 mM imidazole-SO4 pH 7.5. CopB was eluted with JD-buffer containing 200 mM
imidazole-SO4 pH 7.5. The fractions were analyzed by 10% SDS-PAGE [40] and protein bands
were visualized by staining with colloidal Coomassie blue (Figure D in S1 File). The fractions
containing CopB were dialyzed against 250 ml of buffer A (20 mM TrisSO4, pH 7.5) contain-
ing 0.05% DM for 2.5 h, followed by freezing at -80 ˚C.
Reconstitution of CopB
To reconstitute CopB into lipid vesicles, 10 mg of soybean phospholipids dissolved in ether
were dried with a stream of N2, followed high vacuum-drying for 10 min. The dried lipids
were suspended in 800 μl of buffer A containing 20 mg of octyl-β-D-glucoside. The clear lipid
micellar solution was equilibrated on ice for at least 10 min. All further steps were carried out
at 4 ˚C. To the lipid solution, 200 μg of purified CopB were added, immediately followed by
dialysis against 100 ml of buffer A for 2.5 h and buffer A containing 1 mM DTT for 14 h.
ATPase assays
ATPase activity of purified CopB as well as reconstituted CopB was measured by determining
the release of Pi by the method of Lanzetta [41]. The 1 ml reaction mixtures for the solubilized
CopB consisted of air-saturated or xenon-saturated 50 mM Na-MES, pH 6.5, 0.1% DM, 2.5
mM DTT, 5 mM MgSO4, 1 μM CuSO4, 1 mg/mL soybean phospholipids, and 3.75 μg of
CopB. The reaction was conducted at 37 ˚C and started by the addition of 1 mM of Na-ATP
pH 7. At 0, 5, 10, 15, and 20 min, 100 μL aliquots were removed and Pi determined as
described [41]. The ATPase activity of reconstituted vesicles was determined similarly, except
that the 1 ml reactions consisted of vesicles containing 7.15 μg of CopB, 50 mM Na-MES, pH
6.5, 2.5 mM DTT, 5 mM MgSO4, 1 μM CuSO4 and 20% (v/v) glycerol. Specific activities were
calculated from the slopes of linear regressions (n = 3).
Results
Effect of xenon on MscL-G22E
The choice to utilize the gain-of-function mutant MscL-G22E instead of the wild-type MscL
was based on the observation that MscL-G22E is spontaneously active in non-stretched mem-
branes while retaining its mechanosensitivity, resulting in a greater open probability [42]. To
exclude side-effects of mechanical disturbance due to increased levels of liquid in the recording
chamber and shaking of the membrane patch, control recordings with xenon-free solution
were performed. As seen in Fig 1A, channel activity remained relatively constant over several
min. Addition of 0.5 ml of Xe-free recording bath solution did not fundamentally change the
gating activity of the channels. After addition of 0.5 mL of Xe-saturated bath solution to the
recording chamber, MscL-G22E became inhibited within 5 ± 2 min (n = 7) (Fig 1B). This is
seen as both a significant decrease in open probability of an ensemble of two spontaneously
active channels (O1, O2) and by suppression of flickering activity.
Xenon-inhibition of MscL and CopB
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We also observed that the fine-structure of gating by MscL-G22E was affected by the pres-
ence of xenon. To visualize these subtle changes in sub-states of the channel, it was necessary
to obtain patches containing only one or two channels. Under these conditions, it became
apparent that in addition to the open and closed states, there are intermediate open states S1,
S2, S3 and S4 (Fig 2). Xenon abolished all open states of MscL-G22E and reduced the activity
of the channel to a very low flickering activity near the closed state.
While the inhibition of the MscL-G22E channel by xenon is clearly apparent, it remains
unclear if this is due to changes of the membrane properties or interaction of xenon with
hydrophobic domains or pockets of the protein. To address this question, we examined the
effect of xenon on the MscL-G22E channel under increased hydrostatic pressure, which has
previously been shown to increase the open-probability of this channel [37]. Fig 3 shows that
upon xenon exposure, MscL-G22E channel activity was reduced to 39 ± 7% (p< 0.0001). A
step-wise increase in hydrostatic pressure reactivated the channels, reaching maximal recovery
at 80 MPa (81 ± 7%, p = 0.01, Fig 3B). Higher hydrostatic pressure did not lead to significantly
higher recovery of activity. Higher hydrostatic pressure, which also results in an increased
xenon partial pressure, pXe, leads to additional thickening of the membrane [4]. If xenon
would act via changes of membrane properties, elevating the hydrostatic pressure would be
expected to induce channel closing, rather than the opening observed here. How pressure reac-
tivates the xenon-inhibited channel remains speculative. It has been proposed that under pres-
sure, water molecules around the hydrophobic gate of MscL-G22E induce hydration of the
Fig 1. Effect of xenon on MscL-G22E spontaneous activity. A. The current induced by MscL-G22E was recorded at a potential of -30 V in Xe-free
buffer. At the arrow, 1/3 volume of xenon-free (Xe-) recording solution was added. B. As in A, but at the arrow, xenon-saturated (Xe+) recording
solution was added. The ordinates indicate the currents corresponding to the closed state (c) and open states (O1, O2) of at least two spontaneously
active channels.
https://doi.org/10.1371/journal.pone.0198110.g001
Xenon-inhibition of MscL and CopB
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hydrophobic lock, thus increasing the opening probability of the channel [37]. This could lead
to a reversal or overriding of xenon inhibition. Whatever the mechanism of high-pressure
reversal of xenon inhibition is, it supports a direct action of xenon on MscL-G22E, rather than
indirect effects via the membrane as the primary inhibitory mechanism.
To strengthen the concept that xenon inhibition can results from direct interaction of
xenon with the protein, rather than the membrane, we also assessed the effects of xenon on the
CopB copper ATPase. The activity of this enzyme can be measured in solution as well as in the
membrane bound state.
Fig 2. Effect of xenon on MscL-G22E activity and sub-state distribution. A. The current induced by a single MscL-G22E channel was
recorded at a potential of -30 V in Xe-free buffer. At the arrow, 1/3 recording chamber volume of xenon-saturated (Xe) recording
solution was added. B. Frequency distribution of conductance events due to open states (O), open sub-states (S1, S2, S3, S4) and closed
states (C) in the absence of xenon. C. As in B, but in the presence of xenon.
https://doi.org/10.1371/journal.pone.0198110.g002
Xenon-inhibition of MscL and CopB
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Fig 3. Reactivation of xenon-inhibited MscL-G22E by hydrostatic pressure. A. Patch-clamp recording with a
membrane patch with an ensemble of>10 channels. Voltage and xenon applications are marked with arrows. The
hydrostatic pressure was increased stepwise as indicated by the abscissa. B. Quantitative evaluation of the effects of
xenon and hydrostatic pressure on MscL-G22E spontaneous activity. The data were collected from recordings like that
shown in A. The error bars indicate the standard error; the number of evaluated recordings, n, is indicated in the bars.
The asterisk indicates a significant difference of p 0.01.
https://doi.org/10.1371/journal.pone.0198110.g003
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Effects of xenon on solubilized CopB
The ATPase activity of the CopB copper ATPase is tightly linked to copper transport, and thus
serves as a measure of transport activity that can effectively be determined on the solubilized
enzyme as well as on the enzyme reconstituted into membrane vesicles [31]. Since CopB natu-
rally possesses a very histidine-rich N-terminal domain, it can be purified by Ni-NTA affinity
chromatography without a need to modify the protein [43]. It could thus be purified from its
native host as a protein which is at least 90% pure (Figure D in S1 File).
Solubilized CopB will have a comparatively small annulus of detergent surrounding the
hydrophobic domain, but not the large hydrophilic portion of the protein harboring the ATP-
binding and -hydrolyzing domains. Xenon-effects observed on lipid bilayers are thus unlikely
to be mimicked by the small detergent annulus. When the activity of solubilized, purified
CopB was measured in the absence of membrane lipids, it amounted to 976 ± 215 nmol min-1
mg-1 (Fig 4A, Table 1). Xenon inhibited this activity by 85%. Since no membrane was present
in this experiment, the observed inhibition suggests that xenon affected the enzyme by directly
targeting the protein.
The addition of phospholipids to solubilized CopB will result in a mixed detergent-phos-
pholipid annulus covering the hydrophobic domain of the protein. The basal activity of CopB
under these conditions was 1046 ± 121 nmol min-1 mg-1 and thus not significantly different
from that in the absence of phospholipids (Fig 4B, Table 1). In the presence of phospholipids,
xenon inhibited CopB somewhat less, namely 75%, versus 85% in the absence of phospholipids
(p< 0.001). However, if xenon were to inhibit CopB via altered phospholipid properties,
higher rather than lower inhibition of CopB would be expected in the presence of phospholip-
ids, Overall, the xenon-inhibition of CopB not integrated into a lipid bilayer suggests direct
xenon-protein interaction.
Effects of xenon on reconstituted CopB
Purified CopB reconstituted into proteoliposomes by the method described here resulted in a
relatively homogeneous population of unilamellar vesicles of 50 to 100 nm diameter (Figure E
in S1 File). Reconstituted CopB exhibited an ATPase activity of 541 ± 81 nmol min-1 mg-1 (Fig
4C and Table 1). The lower activity of this preparation compared to soluble CopB is due to the
random orientation of CopB in the membrane: only molecules with the cytoplasmic, ATP-
binding domain, facing outside of the vesicles can be activated by externally added ATP. The
activity of membrane-bound CopB was reduced to approximately 62% by xenon.
Clearly, the liposome membrane reduced xenon-inhibition of reconstituted CopB. How-
ever, the fact that solubilized CopB is more strongly inhibited by xenon than reconstituted
CopB suggests that the membrane exerts a stabilizing effect on CopB and partly suppresses
xenon inhibition. If membrane effects would inhibit CopB, more extensively, stronger inhibi-
tion of reconstituted CopB by xenon should have been observed. Thus, the reduced xenon-
inhibition of reconstituted CopB corroborates a mechanism of xenon inhibition by direct pro-
tein interaction. Inhibition of an ion-motive ATPase by xenon has not previously been demon-
strated and could have far-reaching implications in terms of general anesthesia.
Discussion
Mechanosensitive channels act as membrane-embedded mechano-electrical switches by open-
ing an ion-conducting pore in response to lipid bilayer deformations. This process is a key to
physiological responses of living organisms to mechanical stimuli, such as in touch, hearing,
or osmoregulation. The osmo-regulatory protein MscL of E. coli changes its diameter from 50
Å to 70 Å when transitioning from the fully closed to the fully open state [44]. This nearly two-
Xenon-inhibition of MscL and CopB
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fold increase of the area occupied by MscL in the membrane explains why MscL readily
responds to membrane lateral pressure and is thus a mechano-sensitive channel. In this study,
we show for the first time that MscL-G22E, a spontaneously active mutant of MscL, is inhib-
ited by xenon. Xenon inhibition of a membrane protein can come about by two fundamentally
different mechanisms: by direct interaction of xenon with the protein, or by changes of the
membrane properties as a consequence of the partitioning of xenon into the membrane.
Xenon readily diffuses into the hydrophobic region of phospholipid bilayers where it forms
clathrates. Modelling studies have shown that Xe atoms are mostly located between the leaflets
of the bilayer [4,5]. Xe binding to the membrane is accompanied by thickening of the mem-
brane and a shift in the phase transition temperature [3][45]. Hydrophobic interactions are
crucial for mechano-sensitive channel gating [23] and changes in membrane properties, such
as the phase transition temperature, viscosity or thickness could well be the explanation of the
xenon-inhibition of MscL-G22E function. In a reconstituted system where the lipid to protein
ratio is typically in excess of 50 and membrane structural proteins are absent, no lateral mem-
brane pressure can build up, even in the presence of xenon. But xenon partitioning into the
membrane leads to membrane thickening, which in principle could inhibit MscL by hydro-
phobic mismatch between the bilayer and the channel protein [23]. Increased hydrostatic pres-
sure enhances membrane thickening and would thus be expected to result in stronger
inhibition of the channel protein. However, the opposite was observed: increased hydrostatic
pressure relived inhibition of MscL-G22E by xenon, which supports a model of xenon-inhibi-
tion of MscL-G22E by interaction with the protein. Clearly, considerable additional work will
be required to elucidate such a mechanism, but it will be important to investigate along these
lines.
The activity of the CopB copper-pumping ATPase can be assessed both in the membrane-
bound and in the solubilized state. The pumping of ions by CopB is directly coupled to ATP
hydrolysis: if pumping is inhibited or the ions to be pumped are absent, no ATP hydrolysis
takes place [46]. Since xenon inhibits the ATPase activity of CopB to the same extent in the
membrane-bound and the solubilized state, the gas most likely acts by direct binding to the
protein. While this mechanism of inhibition of CopB by xenon requires further verification,
xenon-inhibition of an ion-pumping ATPase by xenon per se is novel and has far-reaching
Fig 4. ATPase activity of CopB was measured either without () or with (●) xenon in the buffer. A. Solubilized
CopB in the presence of 0.1% dodecylmaltoside. B. Solubilized CopB in the presence of 0.1% dodecylmaltoside and
10 μg/ml of soybean phospholipids. C. Reconstituted CopB in proteoliposomes. Each data point represents the release
of Pi by 0.337 μg (A, B) or 0.715 μg (C) of CopB. Other details of the measurements were conducted as detailed under
Material and methods. The error bars indicate the standard deviation of three independent experiments (n = 3).
https://doi.org/10.1371/journal.pone.0198110.g004
Table 1. Specific activity and xenon-inhibition of different CopB preparations.
CopB preparation nmol min-1 mg-1a %a Significanceb
Soluble 976 ± 215 100 0.008
Soluble+Xe 155 ± 87 15.0
Soluble+phospholipids 1046 ± 121 100 0.0007
Soluble+phospholipids+Xe 266 ± 109 24.9
Resonstituted 541 ± 81 100 0.0008
Reconstituted+Xe 339 ± 68 62.4
aValues with standard deviation (n = 3).
bSignificance p of the difference was calculated with Student’s t-test (n = 3).
https://doi.org/10.1371/journal.pone.0198110.t001
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ramifications. Eukaryotic cell function depends on the operation of membranous ion pumps,
like the Na,K-ATPase, the Ca-ATPase, or copper ATPases. The two human copper ATPases,
ATP7A and ATP7B are closely related to CopB and other bacterial copper pumps [47] and are
inextricably linked to satisfying systemic and central nervous system requirements for copper
[48]. Copper also plays a key role at the synapse and in synaptic transmission and in the past
decade, a physiological role for copper in regulating neuronal excitability has emerged [49].
Xenon-inhibition of neuronal copper ATPases would of course have far-reaching conse-
quences on brain function and may contribute or even be central to the anesthetic effects of
this noble gas. None of our findings precludes the possibility that in addition to direct action
of xenon on proteins, xenon can affect channel and pump functions by membrane-exerted
mechanisms caused by xenon accumulation in the lipid bilayer.
Conclusion
Xenon is used as an anesthetic in human medicine and consequently, there is great interest in
its molecular mode of action. Since xenon is hydrophobic, it readily partitions into membranes
as well as hydrophobic cavities in proteins. Since there are multiple targets for xenon, the
mechanism of the anesthetic effects of the gas has been difficult to resolve. It is generally
assumed that the anesthetic effect is due to inhibition of one or several gated neuronal chan-
nels. As a proof of concept we here show that the spontaneously gating MscL-G22E mutant of
the E. coli mechano-sensitive MscL channel is also inhibited by xenon. As a second model sys-
tem for an integral membrane protein, the CopB copper ATPase of E. hirae was used. Its activ-
ity can be assessed both, in a membrane-embedded state and in solution. Xenon inhibits CopB
when reconstituted in proteoliposome or when in solution, suggesting that inhibition is gov-
erned by direct interaction of the gas with the protein. Since copper ATPases play a pivotal
role in brain function, the inhibition of copper pumps by xenon points to a novel possible
mode of action of xenon in anesthesia.
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